Schedule 13D ownership disclosure
iBioPharma, Inc.
Security class unavailable · CUSIP: 45107K102
Event date: 2014-11-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,014,873
- Percent of class
- 6.9700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001102948-14-000010
- Form type
- SC 13D
- Filer
- DESANTIS CARL
- CIK
- CIK 1102948
- Filed
- Nov 18, 2014
- Reporting period
- Nov 18, 2014
- Description
- Schedule 13D beneficial ownership